Abstract
Difficulty with attention is an important symptom in many conditions in psychiatry, including neurodiverse conditions such as autism. There is a need to better understand the neurobiological correlates of attention and leverage these findings for individuals in healthcare settings. Nevertheless, it remains unclear if it is possible to build robust dimensional predictive models of attention in neurodiverse populations. Here, we use five datasets to identify and validate functional connectome-based markers of attention. In dataset one, we use connectome-based predictive modelling and observe successful prediction of performance on an in-scan sustained attention task in a neurodiverse sample of youth. The predictions are not driven by confounds, such as head motion. In dataset two, we find the attention network model defined in dataset one generalizes to predict in-scan attention in a separate sample of neurotypical participants performing the same attention task. In datasets three to five, we use connectome-based identification and longitudinal scans to probe the stability of the attention network across months to years in individual participants. Our results help elucidate the brain correlates of attention in neurodiverse youth and support the further development of predictive dimensional models of other clinically-relevant phenotypes.
Competing Interest Statement
JCM consults with Customer Value Partners, Bridgebio, Determined Health, and BlackThorn Therapeutics, has received research funding from Janssen Research and Development, serves on the Scientific Advisory Boards of Pastorus and Modern Clinics, and receives royalties from Guilford Press, Lambert, and Springer.
Funding Statement
This work was supported by the National Institutes of Health (P50MH115716, T32GM007205 to CH and ASG, and TR001864 to ASG).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The institutional review board of Yale University gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
